Influence of Meals and Glycemic Changes on QT Interval Dynamics

Overview

Journal J Clin Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2017 May 26

PMID 28543601

Citations 12

Authors

Brenda Cirincione

Philip T Sager

Donald E Mager

Affiliations

Soon will be listed here.

Abstract

Thorough QT/QTc studies have become an integral part of early drug development programs, with major clinical and regulatory implications. This analysis expands on existing pharmacodynamic models of QT interval analysis by incorporating the influence of glycemic changes on the QT interval in a semimechanistic manner. A total of 21 healthy subjects enrolled in an open-label phase 1 pilot study and provided continuous electrocardiogram monitoring and plasma glucose and insulin concentrations associated with a 24-hour baseline assessment. The data revealed a transient decrease in QTc, with peak suppression occurring approximately 3 hours after the meal. A semimechanistic modeling approach was applied to evaluate temporal delays between meals and subsequent changes that might influence QT measurements. The food effect was incorporated into a model of heart rate dynamics, and additional delayed effects of the meal on QT were incorporated using a glucose-dependent hypothetical transit compartment. The final model helps to provide a foundation for the future design and analysis of QT studies that may be confounded by meals. This study has significant implications for QT study assessment following a meal or when a cohort is receiving a medication that influences postprandial glucose concentrations.

Citing Articles

Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational Analysis.

Lennox A, Sun L, Huang F, Behrs M, Kleiman R, Xue H Clin Transl Sci. 2025; 18(2):e70169.

PMID: 39980062 PMC: 11842220. DOI: 10.1111/cts.70169.

Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studies.

Duncan K, Li R, Maganti L, Kumar A, Stoch S, Walford G Clin Transl Sci. 2024; 17(1):e13715.

PMID: 38266056 PMC: 10777607. DOI: 10.1111/cts.13715.

Glucose and Fructose Supplementation and Their Acute Effects on Electrocardiographic Time Intervals during Anaerobic Cycling Exercise in Healthy Individuals: A Secondary Outcome Analysis of a Double-Blind Randomized Crossover-Controlled Trial.

Eckstein M, Zimmermann P, Erlmann M, Wachsmuth N, Haupt S, Zimmer R Nutrients. 2022; 14(16).

PMID: 36014763 PMC: 9414006. DOI: 10.3390/nu14163257.

Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study.

Tehranchi R, Pettersson J, Melgaard A, Seitz F, Valeur A, Maarbjerg S Curr Ther Res Clin Exp. 2022; 96:100668.

PMID: 35464292 PMC: 9026613. DOI: 10.1016/j.curtheres.2022.100668.

Influence of heart rate correction formulas on QTc interval stability.

Andrsova I, Hnatkova K, Sisakova M, Toman O, Smetana P, Huster K Sci Rep. 2021; 11(1):14269.

PMID: 34253795 PMC: 8275798. DOI: 10.1038/s41598-021-93774-9.

References

Garnett C, Beasley N, Bhattaram V, Jadhav P, Madabushi R, Stockbridge N . Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review. J Clin Pharmacol. 2007; 48(1):13-8. DOI: 10.1177/0091270007307881. View

Tornoe C, Garnett C, Wang Y, Florian J, Li M, Gobburu J . Creation of a knowledge management system for QT analyses. J Clin Pharmacol. 2010; 51(7):1035-42. DOI: 10.1177/0091270010378408. View

Darpo B, Sager P, MacConell L, Cirincione B, Mitchell M, Han J . Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects. Br J Clin Pharmacol. 2012; 75(4):979-89. PMC: 3612716. DOI: 10.1111/j.1365-2125.2012.04416.x. View

Malik M, Garnett C, Zhang J . Thorough QT Studies: Questions and Quandaries. Drug Saf. 2009; 33(1):1-14. DOI: 10.2165/11319160-000000000-00000. View

Fridericia L . The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920. Ann Noninvasive Electrocardiol. 2003; 8(4):343-51. PMC: 7328879. DOI: 10.1046/j.1542-474x.2003.08413.x. View

Dayneka N, Garg V, Jusko W . Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm. 1993; 21(4):457-78. PMC: 4207304. DOI: 10.1007/BF01061691. View

Florian J, Tornoe C, Brundage R, Parekh A, Garnett C . Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies. J Clin Pharmacol. 2011; 51(8):1152-62. DOI: 10.1177/0091270010381498. View

Parati G, Castiglioni P, Di Rienzo M, Omboni S, Pedotti A, Mancia G . Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. Hypertension. 1990; 16(4):414-21. DOI: 10.1161/01.hyp.16.4.414. View

Guo Y, Stein P . Circadian rhythm in the cardiovascular system: considerations in non-invasive electrophysiology. Card Electrophysiol Rev. 2002; 6(3):267-72. DOI: 10.1023/a:1016337210738. View

10.

Taubel J, Ferber G, Lorch U, Batchvarov V, Savelieva I, Camm A . Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects. Br J Clin Pharmacol. 2013; 77(1):170-9. PMC: 3895358. DOI: 10.1111/bcp.12168. View

11.

Lima J, Matsushima N, Kissoon N, Wang J, Sylvester J, Jusko W . Modeling the metabolic effects of terbutaline in beta2-adrenergic receptor diplotypes. Clin Pharmacol Ther. 2004; 76(1):27-37. DOI: 10.1016/j.clpt.2004.03.006. View

12.

Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G . Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation. 1990; 81(2):537-47. DOI: 10.1161/01.cir.81.2.537. View

13.

Sidery M, MacDonald I . The effect of meal size on the cardiovascular responses to food ingestion. Br J Nutr. 1994; 71(6):835-48. DOI: 10.1079/bjn19940190. View

14.

Taubel J, Wong A, Naseem A, Ferber G, Camm A . Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies. J Clin Pharmacol. 2011; 52(10):1558-65. DOI: 10.1177/0091270011419851. View

15.

Cirincione B, LaCreta F, Sager P, Mager D . Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV Infusion. J Clin Pharmacol. 2017; 57(8):956-965. PMC: 5518197. DOI: 10.1002/jcph.882. View

16.

Jauslin P, Silber H, Frey N, Gieschke R, Simonsson U, Jorga K . An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics. J Clin Pharmacol. 2007; 47(10):1244-55. DOI: 10.1177/0091270007302168. View

17.

Lee S, Harris N, Robinson R, Davies C, Ireland R, MacDonald I . Effect of atenolol on QTc interval lengthening during hypoglycaemia in type 1 diabetes. Diabetologia. 2005; 48(7):1269-72. DOI: 10.1007/s00125-005-1796-1. View

18.

Zhang J, Machado S . Statistical issues including design and sample size calculation in thorough QT/QTc studies. J Biopharm Stat. 2008; 18(3):451-67. DOI: 10.1080/10543400802020938. View

19.

Malik M . Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol. 2001; 12(4):411-20. DOI: 10.1046/j.1540-8167.2001.00411.x. View

20.

Dekker J, Feskens E, Schouten E, Klootwijk P, Pool J, Kromhout D . QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes. 1996; 45(3):376-80. DOI: 10.2337/diab.45.3.376. View